Hospital Universitario Austral
Pilar, Buenos Aires, 1631, Argentina
Location status: Recruiting
NCT Number: NCT04040777
CARFARE (CARDIOMETABOLIC RISK FACTORS REGISTRY) is a registry done in the context of a cardiovascular primary prevention program of the Cardiometabolic Unit Officia of the Cardiology Department of the Austral University Hospital. The structured and sequential evaluation include measurement of anthropometric parameters (body mass index, BMI), laboratory with metabolic profile, baseline electrocardiogram, blood pressure (BP) measurement, arterial stiffness, subclinical atherosclerosis screening in the carotid and ileo-femoral territories using echo-doppler, echocardiogram, and ergometry test.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Pilar, Buenos Aires, 1631, Argentina
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years
Inicidence of myocardial infarction, stroke, unstable angina or acute heart failure
Time frame: 5 years
Death due to MACE or other causes
Contact information is provided by the study sponsor or research team.
Austral University, Argentina
Other
Acronym: CARFARE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03221127
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT00005365
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT01399385
Arterial Occlusive Diseases, Arteriosclerosis
Bethesda, Maryland, United States
View Trial DetailsNCT06694012
Arterial Occlusive Diseases, Arteriosclerosis
Sakai, Osaka, Japan
View Trial Details